NOREPIN is the leading branded generic norepinephrine solution in the Philippines. It is among the Top 200 hospital ethical products based on Dec 2018 IQVIA Report. It was the first norepinephrine brand available with 10 mL preparation in the Philippines. The product provides quality treatment to patients compared to the existing 4 mL preparations available in the country. Moreover, it is the first-line vasopressor for hypotension due to shock.
NOREPIN was launched by Delex Pharma in April 2011. The product is manufactured by United Biotech of India, a multinational business entity with WHO-CGMP and ISO 9001:2008. It is one of the multi-core pharmaceutical companies in India.
NOREPIN is available in almost major tertiary hospitals and selected Mercury Drug branches.
DISCLAIMER: The following contents are intended for healthcare professionals only. If you are a patient or general mass viewing this site, we advise you to clarify with your doctor any information you read herein.
|
Generic Name:
|
NOREPINEPHRINE
|
|
Brand Name:
|
NOREPIN
|
|
Sizes:
|
1 mg/mL (2 mL, 4mL & 10 mL)
|
|
Preparation:
|
1 mg/mL (2 mL, 4mL & 10 mL); Solution for injection
|
|
Name of Manufacturer
|
United Biotech Pvt. Ltd.
|
|
Place of Manufacturer:
|
India
|
|
Shelf Life
|
24 months
|
|
Storage Condition:
|
Store at temperature not exceeding 30 ͦC
|
|
Packaging:
|
USP Type I Amber color glass ampoule in 2 mL and 4 mL box of 5’s; 10 mL box of 1’s
|
|
FDA Registration:
|
DR-XY38818
|
